High-Quality RAD 140 for Sale – Tested & Proven
RAD 140 is a type of SARM, a compound designed to target androgen receptors in the body. These receptors are found in muscles and bones, and when activated, they can help build muscle and improve strength. Unlike traditional steroids, RAD 140 is selective, meaning it focuses on specific tissues and aims to reduce unwanted side effects. It's mainly used for research purposes, as it's not approved for human consumption.
Researchers are interested in RAD 140 because it shows promise in areas like muscle growth, fat loss, and even neuroprotection. Studies have explored its effects on animals, showing it can increase muscle mass and protect brain cells from damage. For example, one study found RAD 140 reduced cell death in rat neurons, which could have implications for diseases like Alzheimer's.
When looking for RAD 140 for sale, quality is critical. Not all suppliers offer pure or safe products. Low-quality RAD 140 might not work as intended or could contain harmful impurities. High-quality RAD 140 should be: Third-Party Tested : This means an independent lab checks the product for purity and strength. Reputable suppliers like PureRawz provide Certificates of Analysis (CoA) to prove their products are clean and effective.
: This means an independent lab checks the product for purity and strength. Reputable suppliers like PureRawz provide Certificates of Analysis (CoA) to prove their products are clean and effective. Pure : The product should be at least 98% pure to ensure it delivers the desired effects without contaminants.
: The product should be at least 98% pure to ensure it delivers the desired effects without contaminants. Well-Packaged : Good packaging keeps the product safe and shows the supplier cares about quality. PureRawz, for instance, uses clean, sealed packaging with clear labeling.
: Good packaging keeps the product safe and shows the supplier cares about quality. PureRawz, for instance, uses clean, sealed packaging with clear labeling. Backed by Reputation: Suppliers with a strong track record, like PureRawz, are trusted because they respond to customer questions and maintain high standards.
Choosing a trusted supplier ensures you're getting a product that's safe for research and meets high standards.
RAD 140 has caught attention for its potential benefits in research. Here's what studies and user experiences suggest:
RAD 140 is known for helping build lean muscle. In animal studies, it increased body weight in young primates, showing strong anabolic effects. This makes it a popular choice for researchers studying muscle hypertrophy. Many users report noticeable muscle gains after a few weeks, especially when combined with exercise. One user shared that after nine weeks of RAD 140 at 20-30 mg daily, they saw enhanced lean muscle growth with a 'dry, grainy look.'
Researchers have found RAD 140 can boost strength and stamina. In one case, a 64-year-old man reported cutting his bike commute time from 60 minutes to under 25 minutes after using RAD 140 for two months. This suggests it could help improve physical performance in research settings.
RAD 140 may help burn fat while preserving muscle. Its ability to increase muscle mass can raise metabolism, which supports fat loss. This makes it appealing for studies on body composition.
Beyond muscle, RAD 140 shows promise in protecting brain cells. In rat studies, it reduced cell death caused by harmful substances, suggesting potential benefits for brain health research.
Compared to steroids, RAD 140 is designed to have fewer side effects. It targets muscles and bones without affecting other tissues, like the prostate. However, researchers must still follow safety guidelines, as long-term effects are not fully studied.
Quality testing is a big deal when buying RAD 140. Reputable suppliers like PureRawz use third-party labs to verify their products. Here's how it works: Purity Testing : Labs check that the RAD 140 is at least 98% pure. This ensures it's free from harmful fillers or contaminants.
: Labs check that the RAD 140 is at least 98% pure. This ensures it's free from harmful fillers or contaminants. Certificates of Analysis (CoA) : These documents show the exact composition of the product. Pure Rawz provides CoAs for transparency, so researchers know what they're getting.
: These documents show the exact composition of the product. Pure Rawz provides CoAs for transparency, so researchers know what they're getting. Consistency: Each batch is tested to ensure it meets the same high standards every time.
When buying RAD 140, always ask for proof of third-party testing. Suppliers like PureRawz make this easy by sharing lab reports on their website.
PureRawz is a well-known name in the SARMs community, and for good reason. Here's why researchers choose them: Third-Party Testing : Every product, including RAD 140, is tested by independent labs. This builds trust and ensures quality.
: Every product, including RAD 140, is tested by independent labs. This builds trust and ensures quality. Fast Shipping : Orders are fulfilled from the USA, so shipping is quick and reliable. Many users report receiving their orders in 3-15 days.
: Orders are fulfilled from the USA, so shipping is quick and reliable. Many users report receiving their orders in 3-15 days. Wide Selection : PureRawz offers RAD 140 in various forms, like liquid, capsules, or stacks with other compounds like YK-11 or MK-677. This gives researchers flexibility.
: PureRawz offers RAD 140 in various forms, like liquid, capsules, or stacks with other compounds like YK-11 or MK-677. This gives researchers flexibility. Customer Support : They're known for quick responses to questions, which is helpful for researchers with specific needs.
: They're known for quick responses to questions, which is helpful for researchers with specific needs. Discounts: PureRawz often provides discount codes, like CAPRED25 for 15% off, making it more affordable to buy high-quality RAD 140.
However, some users have reported slow shipping times, with delays up to 3.5 weeks. Despite this, the consensus is that PureRawz delivers legitimate, high-quality products.
RAD 140 is typically studied in doses of 10-20 mg per day, though this can vary based on the research goals. Here are some tips for safe research: Start Low : Begin with a smaller dose, like 10 mg, to see how it affects the study subject.
: Begin with a smaller dose, like 10 mg, to see how it affects the study subject. Cycle Properly : Researchers often use RAD 140 for 8-12 weeks, followed by a break to avoid potential tolerance buildup.
: Researchers often use RAD 140 for 8-12 weeks, followed by a break to avoid potential tolerance buildup. Post-Cycle Therapy (PCT) : Some studies include PCT compounds, like Arimistane, to balance hormones after a cycle. PureRawz offers PCT products for this purpose.
: Some studies include PCT compounds, like Arimistane, to balance hormones after a cycle. PureRawz offers PCT products for this purpose. Follow Guidelines: RAD 140 is for research only, not human consumption. Always follow local regulations and consult an Institutional Review Board (IRB) for clinical studies.
When buying RAD 140, stick to trusted suppliers. PureRawz is a top choice due to its focus on quality and transparency. Other options include: Paradigm Peptides : Known for fast delivery and positive user reviews. One user reported great results with no side effects after using their RAD 140.
: Known for fast delivery and positive user reviews. One user reported great results with no side effects after using their RAD 140. BehemothLabz : Offers lab-synthesized RAD 140 with third-party testing and fast shipping.
: Offers lab-synthesized RAD 140 with third-party testing and fast shipping. Sports Technology Labs : Sells liquid RAD 140 with 98%+ purity, bottled in the USA.
: Sells liquid RAD 140 with 98%+ purity, bottled in the USA. Chemyo: Praised for affordable powder options, though you'll need a precision scale for accurate dosing.
Always check for third-party testing and read user reviews before buying. Avoid suppliers with poor customer service or no lab reports, as some Reddit users have warned about inconsistent experiences with certain vendors.
While RAD 140 is promising, there are risks to consider: Not for Human Use : RAD 140 is sold for research only. It's not approved by the FDA or allowed by organizations like WADA.
: RAD 140 is sold for research only. It's not approved by the FDA or allowed by organizations like WADA. Potential Side Effects : Though designed to minimize side effects, some researchers note temporary issues like fatigue or hormonal changes. Always monitor study subjects closely.
: Though designed to minimize side effects, some researchers note temporary issues like fatigue or hormonal changes. Always monitor study subjects closely. Supplier Reliability : Some suppliers, including PureRawz, have faced complaints about slow shipping. Double-check stock availability before ordering.
: Some suppliers, including PureRawz, have faced complaints about slow shipping. Double-check stock availability before ordering. Legal Issues: Ensure your research complies with local laws, as SARMs are regulated in many areas.
Finding high-quality RAD 140 for Sale is easier when you choose a trusted supplier like PureRawz. With third-party testing, fast shipping, and a strong reputation, they're a go-to for researchers studying muscle growth, strength, and neuroprotection. RAD 140 offers exciting potential, but quality matters. Always verify purity, read user reviews, and follow research guidelines to ensure safe and effective studies. Whether you're exploring RAD 140 alone or in stacks, suppliers like PureRawz make it simple to get tested, proven products for your research needs.
TIME BUSINESS NEWS
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
16 hours ago
- Newsweek
Tiny 'Flowers' Offer New Hope Against Alzheimer's and Parkinson's
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Tiny, metallic, flower-shaped nanoparticles may offer fresh hope for patients with neurodegenerative diseases like Alzheimer's and Parkinson's. This is the conclusion of researchers from Texas A&M University, who found that the so-called nanoflowers can protect and heal brain cells. The do this by promoting the health and turnover of mitochondria—the oft-dubbed "powerhouses of the cell" which are responsible for turning food into energy. While this process is essential for life, the mitochondria also produce waste in the process—including so-called "reactive oxygen species"—which can damage cells. The finding could pave the way for new treatments for neurological diseases that address the underlying root causes—in this case mitochondrial health and oxidative stress—instead of just managing symptoms. "We expect that our drug can reverse neuronal damage and consequently reverse neurodegeneration," study lead and biochemist professor Dmitry Kurouski told Newsweek. Alzheimer's is the most common neurodegenerative disease with Parkinson's coming in second—and promising new treatments are much sought after. In fact, more than seven million Americans are living with Alzheimer's, a figure projected to rise to nearly 13 million by 2050, according to the Alzheimer's Association. Meanwhile, around 1.1 million people in the U.S. are living with Parkinson's, expected to rise to 1.2 million by 2030, according to Parkinson's Foundation. Alongside potentially helping combat Alzheimer's and Parkinson's, Kurouski said, "it is important to mention that similar reversing effects could be expected in other pathologies including acute brain and spinal cord injuries." Doctor and older patient smile while looking at phone results, with inserted image of nanoflowers overlayed in corner. Doctor and older patient smile while looking at phone results, with inserted image of nanoflowers overlayed in corner. Lacheev / iStock / Getty Images Plus / Journal of Biological Chemistry In their study, Kurouski and colleagues explored—in a petri dish in the lab—how nanoflowers affect both the brain's nerve cells, or 'neurons', and the star-shaped 'astrocytes' that support them. Within 24 hours of treatment, the team saw a "dramatic" drop in the levels of ROS, accompanied by signs of improved mitochondrial function. "Even in healthy cells, some oxidative stress is expected. But the nanoflowers seem to fine-tune the performance of mitochondria, ultimately bringing the levels of their toxic byproducts down to almost nothing," Kurouski explained. Having assessed the effects on individual cells, the researchers next tested the impact of the nanoflowers on whole creatures—specifically a species of worm, C. elegans, which is commonly used as a model organism in neurological research. The team found that, on average, worms treated with one specific flavor of nanoflower survived for days longer than their untreated counterparts (which typically live for around 18 days) and were less likely to die during the early stages of their lives. "These nanoflowers look beautiful under a microscope, but what they do inside the cell is even more impressive," Kurouski said in a statement. "By improving the health of brain cells, they help address one of the key drivers of neurodegenerative diseases that have long resisted therapeutic breakthroughs." With more research needed before clinical trials could be conducted on humans, Kurouski says he plans to undertake further studies in more complex animal models. The team are also exploring practical concerns towards clinical applications. "We are currently working on finding the best way to administrate the drug. We anticipate that internasal spray will be the best solution," Kurouski said. The biochemist stressed that he is keen to make sure the nanoflowers are safe, effective and have clear mechanism of action—but, he concluded, he thinks they could be a "new class of therapeutics" with "incredible potential." Do you have a health story to share with Newsweek? Do you have a question about the study? Let us know via health@ Reference Mitchell, C. L., Matveyenka, M., & Kurouski, D. (2025). Neuroprotective properties of transition metal dichalcogenide nanoflowers alleviate acute and chronic neurological conditions linked to mitochondrial dysfunction. Journal of Biological Chemistry, 301(5).
Yahoo
a day ago
- Yahoo
'Significant evidence' ties air pollution with dementia, study finds
ST. PAUL, Minn., July 24 (UPI) -- British researchers said Thursday they've found "significant evidence" of a long-suspected link between air pollution and dementia after studying data from nearly 30 million people across four continents. The authors of a paper published in The Lancet Planetary Health reviewed data compiled from 32 studies that involved more than 29 million participants, mostly from high-income countries in Europe, North America and Asia, as well as Australia, to "provide more robust overarching conclusions" about the suspected connection. After crunching the numbers from those studies, University of Cambridge researchers said they had identified a "positive and statistically significant association" between dementia and long-term exposure to three types of air pollutants: fine particulate matter with diameters of 2.5 microns or less, nitrogen dioxide, and soot from sources such as vehicle exhaust emissions and burning wood. They also concluded the risks of dementia go up as the levels of exposure increase, especially for the tiny particulate matter, which is so small it can be inhaled deeply into the lungs. For such "PM2.5," every 10 micrograms per cubic meter (μg/m³) of long-term exposure increases an individual's relative risk of dementia by 17%, they found. To put that into perspective, they noted the average roadside measurement for PM2.5 in central London in 2023 was 10 μg/m³. Similarly, for every 10 μg/m³ of long-term exposure to nitrogen dioxide, the relative risk of dementia increased by 3%, while the dementia risk jumped by 13% for each 1 μg/m³ of soot exposure. The study, which was funded by the European Union's scientific research arm, also noted that while traffic-related air pollution is common in cities in high-income countries, "marginalized groups" from low- and middle-income nations and communities not included in the analysis tend to have higher exposures to air pollution and are likely at even greater risk. Senior author Dr. Haneen Khreis of Cambridge's MRC Epidemiology Unit said the findings provide "further evidence to support the observation that long-term exposure to outdoor air pollution is a risk factor for the onset of dementia in previously healthy adults." She added that the mounting evidence makes the case for cleaner air even stronger -- not only for the sake of human health but also for the ability of care systems to cope with the exploding numbers of Alzheimer's disease and other types of dementia. The 57 million people already affected worldwide are expected to almost triple to 153 million cases by 2050, and reducing that avalanche of future illness will require "less burning of fossil fuels, a move to renewable clean energy, a move to clean transportation options, such as walking and cycling, and enacting climate change mitigation strategies," Khreis told UPI in emailed comments. "A coordinated effort would be a multisector, systems-level response -- not unlike how we've approached other public health crises." She and her Cambridge colleagues two years ago created an interactive "evidence map" of hundreds of possible urban policy interventions available by geography to reduce traffic-related emissions and air pollution, which they set up as an aid for planners to become aware of options of which they may not have been previously aware. "There are indeed many options available," Khreis said. "But in short, we need a whole-of-government and whole-of-society approach that views air pollution mitigation as an upstream intervention for brain health, and so many other outcomes that are now convincingly linked to air pollution. We need political will and courage to address this health hazard." Suspected in brain inflammation Scientists has been seeking to establish a definitive link between air pollution and dementia for a decade, as several previous studies have suggested such a connection. For instance, the British government's Committee on the Medical Effects of Air Pollutants reviewed nearly 70 studies in human populations and reported in 2022 that "it is likely that air pollution does contribute" to a decline in mental ability and dementia in older people, although they qualified that more research is needed before recommendations could be issued "with confidence." The 2024 Lancet Commission on dementia prevention, intervention and care, meanwhile, identified air pollution as one of 14 modifiable risk factors for dementia. Most theories about the link center around how air pollution can trigger inflammation in the brain and "excessive oxidative stress," in which the body's ability to combat free radicals with antioxidants is overwhelmed. There is "a wealth of expanding literature that investigates this question," Khreis said, noting that some research indicates the ultrafine particles may be able to bypass the blood-brain barrier and enter the brain directly via the olfactory nerve, thus triggering inflammation. Indirectly, these inhaled pollutants can trigger systemic inflammation and immune responses, such as when they enter the circulatory system and travel to solid organs. The particles can cross into the brain and disrupt microglial function and promote amyloid-β plaque formation, which is associated with dementia, she said. Experts comment Experts and other researchers who have looked at the possible link between air pollution and dementia, but were not connected to the current study, weighed on its findings when contacted by UPI. Dr. Isolde Radford, senior policy manager at the British charitable group Alzheimer's Research U.K., agreed that air pollution "is not just an environmental issue -- it's a serious and growing threat to our brain health. If no one were exposed to air pollution, there would be three fewer cases of dementia for every 100 people who develop it now." She called the current study a "rigorous review [that] adds to mounting evidence that exposure to air pollution -- from traffic fumes to wood burners -- increases the risk of developing dementia," and specifically noted marginalized groups are often exposed to higher levels of pollution, yet remain underrepresented in research. "Future studies must reflect the full diversity of society -- because those most at risk could stand to benefit the most from action," Radford added, calling on the British government to institute a "bold, cross-government approach to health prevention -- one that brings together departments beyond health ... to take coordinated action on the drivers of dementia risk" and move up existing timelines to produce cleaner air. Dr. Hao Chen, a researcher at Guangdong Provincial People's Hospital in China and author of a recent study linking atmospheric pollutants with the progression of cardiometabolic disorders and subsequent dementia, called the Cambridge paper an important document. "This is a landmark study that significantly advances our understanding of the link between air pollution and dementia," he told UPI in emailed comments, noting it is "the largest and most comprehensive meta-analysis to date, significantly advancing previous reviews by including new pollutants and rigorous bias/certainty assessments." It reinforces the findings of the 2024 Lancet Commission, he said, adding, "The public health implications are profound. The findings suggest that efforts to reduce air pollution -- particularly from traffic and industrial sources -- could play a crucial role in lowering the global burden of dementia. "Investing in cleaner air is not only beneficial for respiratory and cardiovascular health; it is a critical investment in protecting our brain health and cognitive longevity. This research provides a compelling, evidence-based mandate for policymakers worldwide to implement stricter air quality standards as an urgent dementia prevention strategy," Chen said. Victoria Williams, an assistant professor of geriatrics and gerontology, and noted Alzheimer's disease researcher at the University of Wisconsin, said the findings suggest "a moderate level of certainty that outdoor air pollution exposure increases risk for dementia, with the studies included considered to be at minimal risk for bias." Since there is currently no cure for dementia, "prevention is key to reducing its overall incidence in our society," she added. "Thus, minimizing exposure to air pollution does reflect a promising strategy in reducing the overall burden of dementia," and unlike other known risk factors linked to lifestyle choices such as smoking and a poor diet, societal action could make a difference. "Limiting exposure to ambient air pollution is well adept to being addressed at a policy level where reductions can offer broad protective effects to a society as a whole," Williams said.
UPI
a day ago
- UPI
'Significant evidence' ties air pollution with dementia, study finds
Smoke from fires in Northern California covers the Bay Bridge in San Francisco in 2020. A British study published this week appears to strengthen the suspected link between long-term exposure to air pollution and the risk of dementia in the elderly. File Photo by Terry Schmitt/UPI | License Photo ST. PAUL, Minn., July 24 (UPI) -- British researchers said Thursday they've found "significant evidence" of a long-suspected link between air pollution and dementia after studying data from nearly 30 million people across four continents. The authors of a paper published in The Lancet Planetary Health reviewed data compiled from 32 studies that involved more than 29 million participants, mostly from high-income countries in Europe, North America and Asia, as well as Australia, to "provide more robust overarching conclusions" about the suspected connection. After crunching the numbers from those studies, University of Cambridge researchers said they had identified a "positive and statistically significant association" between dementia and long-term exposure to three types of air pollutants: fine particulate matter with diameters of 2.5 microns or less, nitrogen dioxide, and soot from sources such as vehicle exhaust emissions and burning wood. They also concluded the risks of dementia go up as the levels of exposure increase, especially for the tiny particulate matter, which is so small it can be inhaled deeply into the lungs. For such "PM2.5," every 10 micrograms per cubic meter (μg/m³) of long-term exposure increases an individual's relative risk of dementia by 17%, they found. To put that into perspective, they noted the average roadside measurement for PM2.5 in central London in 2023 was 10 μg/m³. Similarly, for every 10 μg/m³ of long-term exposure to nitrogen dioxide, the relative risk of dementia increased by 3%, while the dementia risk jumped by 13% for each 1 μg/m³ of soot exposure. The study, which was funded by the European Union's scientific research arm, also noted that while traffic-related air pollution is common in cities in high-income countries, "marginalized groups" from low- and middle-income nations and communities not included in the analysis tend to have higher exposures to air pollution and are likely at even greater risk. Senior author Dr. Haneen Khreis of Cambridge's MRC Epidemiology Unit said the findings provide "further evidence to support the observation that long-term exposure to outdoor air pollution is a risk factor for the onset of dementia in previously healthy adults." She added that the mounting evidence makes the case for cleaner air even stronger -- not only for the sake of human health but also for the ability of care systems to cope with the exploding numbers of Alzheimer's disease and other types of dementia. The 57 million people already affected worldwide are expected to almost triple to 153 million cases by 2050, and reducing that avalanche of future illness will require "less burning of fossil fuels, a move to renewable clean energy, a move to clean transportation options, such as walking and cycling, and enacting climate change mitigation strategies," Khreis told UPI in emailed comments. "A coordinated effort would be a multisector, systems-level response -- not unlike how we've approached other public health crises." She and her Cambridge colleagues two years ago created an interactive "evidence map" of hundreds of possible urban policy interventions available by geography to reduce traffic-related emissions and air pollution, which they set up as an aid for planners to become aware of options of which they may not have been previously aware. "There are indeed many options available," Khreis said. "But in short, we need a whole-of-government and whole-of-society approach that views air pollution mitigation as an upstream intervention for brain health, and so many other outcomes that are now convincingly linked to air pollution. We need political will and courage to address this health hazard." Suspected in brain inflammation Scientists has been seeking to establish a definitive link between air pollution and dementia for a decade, as several previous studies have suggested such a connection. For instance, the British government's Committee on the Medical Effects of Air Pollutants reviewed nearly 70 studies in human populations and reported in 2022 that "it is likely that air pollution does contribute" to a decline in mental ability and dementia in older people, although they qualified that more research is needed before recommendations could be issued "with confidence." The 2024 Lancet Commission on dementia prevention, intervention and care, meanwhile, identified air pollution as one of 14 modifiable risk factors for dementia. Most theories about the link center around how air pollution can trigger inflammation in the brain and "excessive oxidative stress," in which the body's ability to combat free radicals with antioxidants is overwhelmed. There is "a wealth of expanding literature that investigates this question," Khreis said, noting that some research indicates the ultrafine particles may be able to bypass the blood-brain barrier and enter the brain directly via the olfactory nerve, thus triggering inflammation. Indirectly, these inhaled pollutants can trigger systemic inflammation and immune responses, such as when they enter the circulatory system and travel to solid organs. The particles can cross into the brain and disrupt microglial function and promote amyloid-β plaque formation, which is associated with dementia, she said. Experts comment Experts and other researchers who have looked at the possible link between air pollution and dementia, but were not connected to the current study, weighed on its findings when contacted by UPI. Dr. Isolde Radford, senior policy manager at the British charitable group Alzheimer's Research U.K., agreed that air pollution "is not just an environmental issue -- it's a serious and growing threat to our brain health. If no one were exposed to air pollution, there would be three fewer cases of dementia for every 100 people who develop it now." She called the current study a "rigorous review [that] adds to mounting evidence that exposure to air pollution -- from traffic fumes to wood burners -- increases the risk of developing dementia," and specifically noted marginalized groups are often exposed to higher levels of pollution, yet remain underrepresented in research. "Future studies must reflect the full diversity of society -- because those most at risk could stand to benefit the most from action," Radford added, calling on the British government to institute a "bold, cross-government approach to health prevention -- one that brings together departments beyond health ... to take coordinated action on the drivers of dementia risk" and move up existing timelines to produce cleaner air. Dr. Hao Chen, a researcher at Guangdong Provincial People's Hospital in China and author of a recent study linking atmospheric pollutants with the progression of cardiometabolic disorders and subsequent dementia, called the Cambridge paper an important document. "This is a landmark study that significantly advances our understanding of the link between air pollution and dementia," he told UPI in emailed comments, noting it is "the largest and most comprehensive meta-analysis to date, significantly advancing previous reviews by including new pollutants and rigorous bias/certainty assessments." It reinforces the findings of the 2024 Lancet Commission, he said, adding, "The public health implications are profound. The findings suggest that efforts to reduce air pollution -- particularly from traffic and industrial sources -- could play a crucial role in lowering the global burden of dementia. "Investing in cleaner air is not only beneficial for respiratory and cardiovascular health; it is a critical investment in protecting our brain health and cognitive longevity. This research provides a compelling, evidence-based mandate for policymakers worldwide to implement stricter air quality standards as an urgent dementia prevention strategy," Chen said. Victoria Williams, an assistant professor of geriatrics and gerontology, and noted Alzheimer's disease researcher at the University of Wisconsin, said the findings suggest "a moderate level of certainty that outdoor air pollution exposure increases risk for dementia, with the studies included considered to be at minimal risk for bias." Since there is currently no cure for dementia, "prevention is key to reducing its overall incidence in our society," she added. "Thus, minimizing exposure to air pollution does reflect a promising strategy in reducing the overall burden of dementia," and unlike other known risk factors linked to lifestyle choices such as smoking and a poor diet, societal action could make a difference. "Limiting exposure to ambient air pollution is well adept to being addressed at a policy level where reductions can offer broad protective effects to a society as a whole," Williams said.
